Additional file 5 of Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma
Additional file 5. Table C. Response to daratumumab overall and by daratumumab line of treatment.
Institutions
- Qingdao University (CN)
- Nantong University (CN)
- Peking University (CN)
- Sichuan University (CN)
- Sheng Jing Hospital (CN)
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Southern University of Science and Technology (CN)
- Affiliated Hospital of Nantong University (CN)
- Beijing Hospital (CN)
- Qingdao Municipal Hospital (CN)
- Peking University People's Hospital (CN)
- Henan Provincial People's Hospital (CN)
- Henan Cancer Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Figshare
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6084/m9.figshare.28953650.v1
- Primary Topic
- Genetic and Environmental Crop Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00